Enhua Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 1%
- Cancer-related Molecular Pathways
Papers in
-
- Wnt/β-catenin signaling in development and cancer 70
- Cancer-related gene regulation 54
- RNA modifications and cancer 25
- Epigenetics and DNA Methylation 23
- RNA Research and Splicing 17
- Oncology 75
- Cancer-related Molecular Pathways 24
- Co-authors
- Xueshan Qiu (40 shared papers)Qianze Dong (22 shared papers)Yuan Miao (55 shared papers)Xuyong Lin (49 shared papers)Liang Wang (26 shared papers)Hong‐Tao Xu (50 shared papers)Qingchang Li (43 shared papers)Xiupeng Zhang (55 shared papers)
- Journals
- Tumor Biology (32 papers)Diagnostic Pathology (17 papers)PLoS ONE (16 papers)Molecular Carcinogenesis (14 papers)Oncotarget (13 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Enhua Wang
305 papers receiving 6.4k citations
Enhua Wang's Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 1.0k
- Oncology 1.4k
- Cell Biology 903
- Molecular Biology 3.7k
- Immunology and Allergy 164
Countries citing papers authored by Enhua Wang
This map shows the geographic impact of Enhua Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enhua Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enhua Wang more than expected).
Fields of papers citing papers by Enhua Wang
This network shows the impact of papers produced by Enhua Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enhua Wang. The network helps show where Enhua Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Enhua Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma Hit paper breakdown → | 2016 | 444 |
| 2 | 2010 | 289 | |
| 3 | 2010 | 136 | |
| 4 | 2013 | 108 | |
| 5 | 2012 | 95 | |
| 6 | 2009 | 87 | |
| 7 | 2015 | 75 | |
| 8 | 2013 | 66 | |
| 9 | 2009 | 64 | |
| 10 | 2009 | 64 | |
| 11 | 2017 | 62 | |
| 12 | 2013 | 62 | |
| 13 | 2014 | 60 | |
| 14 | 2010 | 60 | |
| 15 | 2010 | 58 | |
| 16 | 2015 | 56 | |
| 17 | 2008 | 55 | |
| 18 | 2014 | 53 | |
| 19 | 2006 | 52 | |
| 20 | 2014 | 51 |
About Enhua Wang
Enhua Wang is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Cancer Research, having authored 308 papers that have together received 6.5k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (70 papers), Cancer-related gene regulation (54 papers), RNA modifications and cancer (25 papers), Cancer-related Molecular Pathways (24 papers), Epigenetics and DNA Methylation (23 papers), Hippo pathway signaling and YAP/TAZ (21 papers), RNA Research and Splicing (17 papers) and Lung Cancer Treatments and Mutations (15 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.4k citations), Cell Biology (903 citations), Molecular Biology (3.7k citations) and Immunology and Allergy (164 citations). Enhua Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Xueshan Qiu, Qianze Dong, Yuan Miao, Xuyong Lin, Liang Wang, Hong‐Tao Xu, Qingchang Li, Xiupeng Zhang, Shun‐Dong Dai and Chuifeng Fan. Their work appears in journals such as Tumor Biology, Diagnostic Pathology, PLoS ONE, Molecular Carcinogenesis and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.